1-[(3R)-1-(2,6-dimethoxyphenyl)pyrrolidin-3-yl]-4-methoxy-3-[[2-(trifluoromethyl)phenyl]methyl]-2H-benzimidazole
C28H30F3N3O3 — CID 139333960
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[(3R)-1-(2,6-dimethoxyphenyl)pyrrolidin-3-yl]-4-methoxy-3-[[2-(trifluoromethyl)phenyl]methyl]-2H-benzimidazole
1-[(3R)-1-(2,6-dimethoxyphenyl)pyrrolidin-3-yl]-4-methoxy-3-[[2-(trifluoromethyl)phenyl]methyl]-2H-benzimidazole (PubChem CID 139333960) has the molecular formula C28H30F3N3O3 and a molecular weight of 513.56 g/mol. Its IUPAC name is 1-[(3R)-1-(2,6-dimethoxyphenyl)pyrrolidin-3-yl]-4-methoxy-3-[[2-(trifluoromethyl)phenyl]methyl]-2H-benzimidazole.
Molecular Properties
| Compound Name | 1-[(3R)-1-(2,6-dimethoxyphenyl)pyrrolidin-3-yl]-4-methoxy-3-[[2-(trifluoromethyl)phenyl]methyl]-2H-benzimidazole |
|---|---|
| PubChem CID | 139333960 |
| Molecular Formula | C28H30F3N3O3 |
| Molecular Weight | 513.56 g/mol |
| Exact Mass | 513.22 |
| IUPAC Name | 1-[(3R)-1-(2,6-dimethoxyphenyl)pyrrolidin-3-yl]-4-methoxy-3-[[2-(trifluoromethyl)phenyl]methyl]-2H-benzimidazole |
| SMILES | COc1cccc(OC)c1N1CC[C@@H](N2CN(Cc3ccccc3C(F)(F)F)c3c(OC)cccc32)C1 |
| InChI | InChI=1S/C28H30F3N3O3/c1-35-23-11-6-10-22-26(23)33(16-19-8-4-5-9-21(19)28(29,30)31)18-34(22)20-14-15-32(17-20)27-24(36-2)12-7-13-25(27)37-3/h4-13,20H,14-18H2,1-3H3/t20-/m1/s1 |
| InChIKey | WUMGTOFRPOLYEL-HXUWFJFHSA-N |
| XLogP | 5.79 |
| TPSA | 37.41 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 513.56 |
| LogP ≤ 5 | 5.79 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139333960 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.